| Olamkicept | Drug candidate: IL-6 trans-signalling inhibitor (licensed to Ferring Pharmaceuticals) |
| CR12/01 | Drug candidate: Modulator of intestinal microbiota (small molecule) |
| CR12/02 | Drug candidate: Modulator of intestinal microbiota (small molecule) |
| CR13/01 | Drug candidate: Transfer of sterile fecal microbiota filtrates (sold in 2017) |
| CR19/01-04 | Food supplement: Combination of intestinal microbiota modulators (out-licensed in 2020) |
16 February, 2022